EN
enGene Holdings Inc. Warrants
ENGNW · NASDAQ
$0.20 -90.48% (-$1.90)
1M -20.06%
Market Cap $10.8M
P/E Ratio -
Div. Yield -
ROE 2.10%
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.05x
EV/FFO N/A
P/E N/A
Growth
78 /100
Growing Book val. growth 9.59%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 1.70%
ROIC 1.61%
Asset turnover 0.00x
Debt
69 /100
Low Int. coverage -44.28x
Debt/Equity 0.03x
Current ratio 9.79x
Stability
19 /100
Unstable Profitable years 0
Beta -0.28x
EPS volatility 128,900.54%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre ENGNW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Ronald H. W. Cooper
Employees
82
Headquarters
Montreal
Evenimente viitoare
23 DEC.
Earnings
Upcoming earnings report